UKRI AstraZeneca (AZ) Small molecule high throughput screen using AZ facilities
Application deadline
Runs twice a year
Next deadline: 09 September 2026
Award volume and duration
up to £270k
Duration not specified
About the call
Supports academic researchers to access AstraZeneca’s compound library and high-throughput screening facilities to identify small molecule starting points for therapeutic development. Two funding opportunities are available each year.
